Neurotech, Neuromodulation, Alzheimers.
opportune time to try some more innovative and lower cost approaches that large health care companies are not financially motivated enough to pursue, or too risk-averse to try. BIG PHARMA FAILURE After close to 10 years of donating money to the Fisher Center for Alzheimer’s Research, I observed